MEDIA RELEASE

For Immediate Release

June 24, 2015

 

LHSC first in North America to implant third generation transcatheter aortic valve

(LONDON, Ontario) –The heart team at London Health Sciences Centre (LHSC) is the first in North America to implant Medtronic’s Engager Valve in a transcatheter aortic valve implantation (TAVI) procedure. The procedure was performed in February, less than one year after the team was the first in North America to implant another second generation TAVI device.

Doug Cameron, 73, from Tilbury, Ontario, the first patient implanted with the device, underwent coronary artery bypass surgery five years ago, but was told at the time ‘it was likely another surgery for his valve would be needed.’ “Earlier this year I began feeling tired again, and it was becoming harder to breathe,” he recalls.

LHSC cardiac physicians, Drs. Michael Chu, Bob Kiaii, Pantelis Diamantouros, Rodrigo Bagur, and Patrick Teefy, agreed TAVI would be the best treatment option and chose to use a new generation device that promises precise valve positioning.

“This new generation device has arms that are inserted into the sinuses of the native valve. Once inserted, the device sits precisely where the valve is supposed to be and is aligned with the individual anatomy of the patient,” says Dr. Diamantouros. The minimally invasive procedure restores normal blood flow through the heart and the rest of the body and reduces paravalvular leakage around the valve.

Cameron “felt ready to go home that same day. I was breathing better and walking soon after I woke up.” Discharged after two days in hospital, he returned to his job in security shortly after his surgery. “I worked in the fishing industry for 25 years and in security these past 10 years. I’ve never missed a day and I’m happy to still be working now.”

“It has been a privilege for our team to perform the first North American implants of this new generation heart valve prosthesis for the betterment of our patients. We believe that early adoption of these newer generation TAVI devices broadens our treatment options to improve the care that we deliver to these very high risk patients, while potentially reducing some periprocedural risks” adds Dr. Chu.

With access to four to four different types of aortic bioprostheses, physicians can select from multiple devices to suit the unique anatomies of patients.

“As medical and surgical technologies continue to evolve, we want to ensure that we are safely providing the latest treatments with the best outcomes to our patients. This can only be accomplished through a team approach. We have successfully implanted this new-generation device in ten other patients,” explains Dr. Kiaii. Currently, special approval from Health Canada is required prior to proceeding with each individual patient.

For Cameron, a successful TAVI implant means “plenty of energy to play with my grandchildren and great-grandchildren.”



About London Health Science Centre
London Health Sciences Centre has been at the forefront of medicine in Canada for 140 years and offers the broadest range of specialized clinical services in Ontario. Building on the traditions of its founding hospitals to provide compassionate care in an academic teaching setting, London Health Sciences Centre is home to Children’s Hospital, University Hospital, Victoria Hospital, the Kidney Care Centre, two family medical centres, and two research institutes – Children’s Health Research Institute and Lawson Health Research Institute. As a leader in medical discovery and health research, London Health Sciences Centre has a history of over 65 international and national firsts and attracts top clinicians and researchers from around the world. As a regional referral centre, London Health Sciences Centre cares for the most medically complex patients including critically injured adults and children in southwestern Ontario and beyond. The hospital’s nearly 15,000 staff, physicians, students and volunteers provide care for more than one million patient visits a year. For more information visit www.lhsc.on.ca


-30-



For media inquiries contact:

Marek Kubow

Corporate Communications and Public Relations
London Health Sciences Centre
519-685-8500 ext. 75155

marek.kubow@lhsc.on.ca

After-hours and weekend assistance:

Call LHSC Switchboard at 519-685-8500 and ask to page the communication consultant on-call.

 

Visit the LHSC Media Room website at www.lhsc.on.ca/media.

Like us on Facebook at London Health Sciences Centre (LHSC), follow us on Twitter @LHSCCanada and watch us on YouTube at LHSCCanada.

 

About Us

Last Updated June 24, 2015 | © 2007, LHSC, London Ontario Canada